ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

ALNYLAM PHARMACEUTICALS INC

Sector: —

Alnylam Pharmaceuticals develops and markets RNA interference (RNAi) therapeutics for rare genetic, cardiometabolic, and other diseases.

4 tracked filer(s) hold this · 1 opened, 1 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 48 — mean of 4 scored holder(s) · buyers (new/add) avg 47. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
George Soros / Soros Fund Mgmt33New buy99,000,000$90,690,9171.1%
Paul Tudor Jones / Tudor61Added +100%2,400$592,1760.0%
Ancora42Holds (flat)11$2,7140.0%
Bridgewater55Trimmed -71%28,463$7,022,9610.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-11-12SCHULMAN AMY Wdirector1,910$299,526Form 4

Trump & executive branch trades all Trump/exec trades →

10 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-10-08Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-10-08Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-09-22Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-08-22Trump, Donald J PresidentSELL$15,001 - $50,000PTR
2026-07-01Trump, Donald J PresidentSELL$1,001 - $15,000PTR
2026-07-01Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-07-01Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-05-14Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-05-14Trump, Donald J PresidentBUY$1,001 - $15,000PTR
2026-05-14Trump, Donald J PresidentSELL$1,001 -$15,000PTR

Citrini Research coverage report library →

ReportDateStance
#135 — State of the Themes: The End of the Trade (As We Know It)2026-11-04WATCH

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.